Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

100.8K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
100.8K
RNA-seq03:21

RNA-seq

12.4K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
12.4K
Wald-Wolfowitz Runs Test I01:17

Wald-Wolfowitz Runs Test I

1.0K
The Wald-Wolfowitz test, also known as the runs test, is a nonparametric statistical test used to assess the randomness of a sequence of two different types of elements (e.g., positive/negative values, successes/failures). It examines whether the order of the elements in a sequence is random or if there is a pattern or trend present. This nonparametric test applies to any ordered data despite the population and sample data distribution, even if a higher sample size is available.
The test works...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gab1 but not Grb2 mediates tumor progression in Met overexpressing colorectal cancer cells.

Carcinogenesis·2008
Same author

Long-term donor-specific tolerance in rat cardiac allografts by intrabone marrow injection of donor bone marrow cells.

Transplantation·2008
Same author

Lsr2 of Mycobacterium tuberculosis is a DNA-bridging protein.

Nucleic acids research·2008
Same author

Amphetamine selectively enhances avoidance responding to a less salient stimulus in rats.

Journal of neural transmission (Vienna, Austria : 1996)·2008
Same author

Retrospective analysis of anterior correction and fusion for adolescent idiopathic thoracolumbar/lumbar scoliosis: the relationship between preserving mobile segments and trunk balance.

International orthopaedics·2008
Same author

Intrarenal antigens activate CD4+ cells via co-stimulatory signals from dendritic cells.

Journal of the American Society of Nephrology : JASN·2008

Related Experiment Video

Updated: Mar 25, 2026

Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

12.7K

Risk Prediction Modeling of Sequencing Data Using a Forward Random Field Method.

Yalu Wen1, Zihuai He2, Ming Li3

  • 1Department of Statistics, University of Auckland, Auckland 1010, New Zealand.

Scientific Reports
|February 20, 2016
PubMed
Summary
This summary is machine-generated.

We developed a novel Forward Random Field (FRF) method for disease risk prediction using sequencing data. FRF improves accuracy by analyzing genetic similarities and adaptively selecting relevant genes, outperforming existing methods.

More Related Videos

Author Spotlight: Investigating the Role of Repetitive DNA Misregulation in Cancer Initiation and Immunotherapy Resistance
04:58

Author Spotlight: Investigating the Role of Repetitive DNA Misregulation in Cancer Initiation and Immunotherapy Resistance

Published on: December 13, 2024

4.8K
Optimization for Sequencing and Analysis of Degraded FFPE-RNA Samples
07:30

Optimization for Sequencing and Analysis of Degraded FFPE-RNA Samples

Published on: June 8, 2020

12.9K

Related Experiment Videos

Last Updated: Mar 25, 2026

Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

12.7K
Author Spotlight: Investigating the Role of Repetitive DNA Misregulation in Cancer Initiation and Immunotherapy Resistance
04:58

Author Spotlight: Investigating the Role of Repetitive DNA Misregulation in Cancer Initiation and Immunotherapy Resistance

Published on: December 13, 2024

4.8K
Optimization for Sequencing and Analysis of Degraded FFPE-RNA Samples
07:30

Optimization for Sequencing and Analysis of Degraded FFPE-RNA Samples

Published on: June 8, 2020

12.9K

Area of Science:

  • Genomics
  • Biostatistics
  • Computational Biology

Background:

  • High-throughput sequencing enables studying common and rare variants for disease risk prediction.
  • Massive data and rare variant frequencies present analytical challenges for current risk prediction models.

Purpose of the Study:

  • To develop a novel Forward Random Field (FRF) method for disease risk prediction using sequencing data.
  • To address the analytical challenges posed by large datasets and low-frequency rare variants in genetic risk prediction.

Main Methods:

  • The Forward Random Field (FRF) method models phenotypes as random fields on a genotype-derived genetic space.
  • FRF predicts phenotypes based on genetic similarity between subjects.
  • The method adaptively selects optimal similarity measures and disease-associated genes, accommodating various genetic effect directions and magnitudes without pre-specifying rare variant thresholds.

Main Results:

  • Simulations show FRF achieves higher or comparable accuracy to support vector machine-based methods across diverse disease models.
  • The FRF method demonstrates robustness in handling complex genetic architectures.
  • Application to Dallas Heart Study sequencing data illustrates FRF's practical utility.

Conclusions:

  • The Forward Random Field (FRF) method offers a powerful and flexible approach for disease risk prediction from sequencing data.
  • FRF effectively integrates genetic information, including rare variants, outperforming conventional methods.
  • This approach holds significant potential for advancing personalized medicine and genetic epidemiology.